JUNE - 20206June - 01 - 2020, volume 04 - Issue 8 Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerJohn GothamSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@Medicaltechoutlook.comAs of now, COVID-19 has infected more than a quarter of a million people globally. With the continued spread of this virus, which can cause pneumonia and difficulty breathing, healthcare facilities are facing a limited supply of ventilators. As the shortage and prevalence of such respiratory diseases increase, the global ventilators market is expected to grow from USD 1.05 billion in 2019 to USD 3.02 billion by 2027. Consequently, the threat will have a lasting impact on governments and regulatory agencies in terms of future preparedness when it comes to the next pandemic. Today, governments worldwide are playing catch-up, swiftly intervening in an attempt to create alliances with manufacturers to handle the COVID-19 threat. And, international regulatory agencies are considering accelerated approval of specific respiratory devices. Bolstered by such a scenario, the entire respiratory market will continue to rise as the global geriatric population grows and the incidence of chronic diseases, such as COPD and asthma, increases. Moving forward beyond the current healthcare crisis, the entire respiratory market will continue to rise as the global population ages along with the exponential increase of chronic diseases. Further, the cost advantages of home care devices and services will be a crucial factor in the growth of respiratory devices. To help medical and healthcare organizations, MedTech Outlook editorial team has cherry-picked some of the most exceptional Respiratory Devices Solution Providers you should be looking up to in 2020.Let us know your thoughts!The Future of European Respiratory TherapeuticsSarah FernandesEDITORIAL
< Page 5 | Page 7 >